Malaria parasite heme metabolism and hemozoin formation — Drug Target

All drugs that target Malaria parasite heme metabolism and hemozoin formation — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antimalarial combination therapy

Marketed (1)

• lumefantrine plus artemether · Centers for Disease Control and Prevention · Antimalarial combination therapy · Infectious Disease
  Lumefantrine and artemether work together as antimalarial agents that kill malaria parasites through distinct mechanisms involving heme detoxification and rapid parasite clearance.